All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 156 of 206 pages ‹ First < 154 155 156 157 158 > Last ›
HSL5655
Herlihyj , Gandy , J
Causation and explanation
The Psychologist 2002 May 1;15:(5):248-251
HSL17911
Temple RJ, Himmel MH.
Safety of newly approved drugs: implications for prescribing.
JAMA 2002 May 1;287:(17):2273-5
http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=11980528
HSL1614
Petty RE, Brinol P, Tormala ZL.
Thought confidence as a determinant of persuasion: the self-validation hypothesis.
J Pers Soc Psychol 2002 May;82:(5):722-41
http://content.apa.org/journals/psp/82/5/722
HSL1973
Panush RS.
Not for sale, not even for rent: just say no. Thoughts about the American College of Rheumatology adopting a code of ethics.
J Rheumatol 2002 May;29:(5):1049-57
http://www.jrheum.com/subscribers/02/05/1049.html
HSL5291
Beckwith H.
Selling the Invisible : A Field Guide to Modern Marketing
New York: Texere 2002
HSL17909
Trotter G.
Why were the benefits of tPA exaggerated?
West J Med 2002 May;176:(3):194-7
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1071715/?tool=pubmed
HSL1766
Mallaby S.
Arthur Andersens of Medicine
Washington Post 2002 Apr 28
http://news.google.com/newspapers?nid=1821&dat=20020504&id=JjUtAAAAIBAJ&sjid=Hr4EAAAAIBAJ&pg=1161,1277740
HSL1770
Pharma John
Drugmarketing in the 21st Century
2002 Apr 27
HSL1765
Medicines in Europe Forum, Medicines policy projects: A threat to consumers and patients
e-drug 2002 Apr 26
http://www.essentialdrugs.org/edrug/archive/200204/msg00108.php
HSL1968
Pope John Paul II.
The profit motive behind too much medical research.
Origins 2002 Apr 25;31:(45):754-5
HSL1763
Hensley S.
New Rules Will Push Drug Firms To New Tactics in Wooing Doctors
The Wall Street Journal 2002 Apr 23
http://online.wsj.com/article/SB101950641556616040.html?mod=googlewsj
HSL1764
Kolata G.
In Public Health, Definitive Data Can Be Elusive
New York Times 2002 Apr 23
http://www.nytimes.com/2002/04/23/science/in-public-health-definitive-data-can-be-elusive.html?pagewanted=1
HSL1762
Brubaker B.
Drug Industry Adopts Guidelines on Giveaways to Doctors
Washington Post 2002 Apr 20
http://www.washingtonpost.com/wp-dyn/articles/A18058-2002Apr19.html
HSL2084
Young JM, Glasziou P, Ward JE.
General practitioners' self ratings of skills in evidence based medicine: validation study.
BMJ 2002 Apr 20;324:(7343):950-1
http://bmj.bmjjournals.com/cgi/content/full/324/7343/950
HSL2475
Dal-Pizzol F.
Drug advertisements in less-developed countries.
Lancet 2002 Apr 20;359:(9315):1439-40
http://linkinghub.elsevier.com/retrieve/pii/S0140673602083836
HSL1757
Grady D.
Scientists Question Hormone Therapies for Menopause Ills
New York Times 2002 Apr 19
http://www.nytimes.com/2002/04/18/us/scientists-question-hormone-therapies-for-menopause-ills.html?pagewanted=1
HSL1758
Pollack A
Despite Billions for Discoveries, Pipeline of Drugs Is Far From Full
The New York Times 2002 Apr 19
http://www.nytimes.com/2002/04/19/business/despite-billions-for-discoveries-pipeline-of-drugs-is-far-from-full.html?pagewanted=1
HSL1759
Agovino T.
Drug industry tightens guidelines on marketing to doctors
AP Business Writer 2002 Apr 19
HSL1760
Clarke T.
Drugmakers Plan New Rules to Cut Perks for Doctors
Reuters 2002 Apr 19
HSL1761
Hensley S.
Drug industry curbs 'dine and dash' marketing
The Wall Street Journal 2002 Apr 19
HSL1755
Parker-Pope T.
Latest Craze in Coupon-Clipping: Free Trials for Prescription Drugs
Wall Street Journal 2002 Apr 16
HSL1756
New Findings on Physicians' Views of Doctors and Prescription Drugs
The Henry J. Kaiser Family Foundation 2002 Apr 16
HSL1754
Jopson D.
Vaccine for Aborigines spurned by drug makers
Sydney Morning Herald 2002 Apr 15
HSL17382
THE 2002 FORTUNE 500 report on the Pharmaceutical Industry
2002 Apr 15
HSL1752
Robotham J.
Illness exaggerated as companies strive to sell more drugs
Sydney Morning Herald 2002 Apr 13
HSL1753
Metherall M.
Drug deals
Sydney Morning Herald 2002 Apr 13
HSL1980
Moynihan R.
Drug firms hype disease as sales ploy, industry chief claims.
BMJ 2002 Apr 13;324:(7342):867
http://bmj.bmjjournals.com/cgi/content/full/324/7342/867
HSL2024
Mintzes B.
For and against: Direct to consumer advertising is medicalising normal human experience: For.
BMJ 2002 Apr 13;324:(7342):908-9
http://bmj.bmjjournals.com/cgi/content/full/324/7342/908
HSL2092
Moynihan R, Heath I, Henry D.
Selling sickness: the pharmaceutical industry and disease mongering.
BMJ 2002 Apr 13;324:(7342):886-91
http://bmj.bmjjournals.com/cgi/content/full/324/7342/886
HSL2491
Bonaccorso S, Sturchio J.
Direct to consumer advertising is medicalising normal human experience: Against
BMJ 2002 Apr 13;324:(7342):910-911
http://bmj.com/cgi/content/full/324/7342/910
HSL7763
Bonaccorso SN, Sturchio JL.
For and against: Direct to consumer advertising is medicalising normal human experience: Against.
BMJ 2002 Apr 13;324:(7342):910-1
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=11950746
HSL1750
O'Malley N.
Ad agencies liable if they mislead
Sydney Morning Herald 2002 Apr 12
HSL1751
Denoon D.
Are Drug Companies Making Us Sick?
WebMD Medical News 2002 Apr 12
HSL1747
Burne J.
The drug pushers
Guardian 2002 Apr 11
HSL1748
Winslow R.
Black Doctors See Drug Ads As Beneficial for Minorities
The Wall Street Journal 2002 Apr 11
HSL1749
Petersen M.
Methods Used for Marketing Arthritis Drug Are Under Fire
New York Times 2002 Apr 11
http://www.nytimes.com/2002/04/11/business/methods-used-for-marketing-arthritis-drug-are-under-fire.html?pagewanted=1
HSL19050
Woloshin S, Schwartz LM, Welch HG.
Risk charts: putting cancer in context.
J Natl Cancer Inst 2002 April 11;94:(11):799-804
http://jnci.oxfordjournals.org/content/94/11/799.long
HSL1746
Metherell M.
Budget to force up drug prices
Sydney Morning Herald 2002 Apr 10
http://www.smh.com.au/articles/2002/04/09/1018333354729.html
HSL11649
Kolata G.
Test Proves Fruitless, Fueling New Debate on Cancer Screening
New York Times 2002 Apr 9
http://www.nytimes.com/2002/04/09/science/09CANC.html?pagewanted=1&ei=5070&en=dfb7e38ab6a9ca5c&ex=1191729600
HSL17384
Stein C
A colorful strategy
The Boston Globe 2002 Apr 9
HSL1745
Giombetti R.
Suicide Science - Dr. David Dunner: Paxil's Friendly Ghostwriter?
www.counterpunch.org 2002 Apr 8
HSL17383
Wilton K
Part 1: Union urges Quebec action to cut pharmaceutical costs
Montreal Gazette 2002 Apr 8
HSL2468
The Editor
Just how tainted has medicine become.
Lancet 2002 April 6;359:(9313):1167
http://linkinghub.elsevier.com/retrieve/pii/S0140673602081989
HSL1743
Robotham J.
Big business, bad medicine cloud our epidemic of the blues
The Sydney Morning Herald 2002 Apr 3
HSL1744
Keon J.
Prescription medicine: "Think of the needs of tax payers before those of the multinationals"
Canadian Drug Manufacturers Association 2002 Apr 3
HSL2486
Cassels A.
Push for consumer drug ads gets cool reception in Europe.
CMAJ 2002 Apr 2;166:(7):946
http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=11949998
HSL1742
Toner R.
Rising Drug Costs a Powerful Issue for National and State Politicians
New York Times 2002 Apr 1
http://www.nytimes.com/2002/04/01/us/rising-drug-costs-a-powerful-issue-for-national-and-state-politicians.html?pagewanted=1
HSL3812
Edmonds JP, Day RO, Bertouch JV.
The road to consensus: considerations for the safe use and prescribing of COX-2-specific inhibitors.
Med J Aust 2002 Apr 1;176:(7):332-4
http://www.mja.com.au/public/issues/176_07_010402/edm10003_fm.html
HSL5849
Toop L, Richards D.
DTCA in New Zealand: the challenge of finding an acceptable balance
Br J Gen Pract. 2002 Apr 1;52:(477):341
HSL17978
Van der Weyden MB.
Clinical practice guidelines: time to move the debate from the how to the who.
Med J Aust 2002 Apr 1;176:(7):304-5
http://www.mja.com.au/public/issues/176_07_010402/martineditorial_fm.html
HSL1921
Viale PH.
Direct-to-consumer advertising of prescription medications: implications for patients with cancer.
Oncol Nurs Forum 2002 Apr;29:(3):505-13
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11979283
HSL2025
Miller FG, Shorr AF.
Ethical assessment of industry-sponsored clinical trials: a case analysis.
Chest 2002 Apr;121:(4):1337-42
http://www.chestjournal.org/cgi/content/full/121/4/1337
HSL2502
[No authors listed].
Roche turns to DM to boost patient compliance with its weight loss drug.
Dis Manag Advis 2002 Apr;8:(4):51-4,
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11995433
HSL7397
Liebman M.
Awakening the Silent Osteoporosis Market
Medical Marketiing and Media 2002 Apr;
http://www.mmm-online.com/content/fileadmin/files/features/2002/Osteo.pdf
HSL1739
Metherell M.
Drug makers told to justify their sky-high prices
Sydney Morning Herald 2002 Mar 30
http://www.smh.com.au/articles/2002/03/29/1017206153767.html
HSL1740
Gordon C.
TV drug ads are tough to swallow
The Ottawa Citizen 2002 Mar 30
HSL1735
Top-Selling Drugs Push Drug Spending Up 17.1% in 2001
2002 Mar 29
HSL1736
Freudenheim M.
Drug Spending Rises Sharply At Pharmacies and by Mail
The New York Times 2002 Mar 29
http://select.nytimes.com/gst/abstract.html?res=F30B13FC345F0C7A8EDDAA0894DA404482
HSL1737
Connolly C.
Medication Spending Continues Steady Rise
Washington Post 2002 Mar 29
HSL1738
Carroll J.
Rise in Prescription-Drug Spending May Mean Steeper Premiums Ahead
The Wall Street Journal 2002, Mar 29
http://online.wsj.com/article/SB1017351626393985960.html?mod=googlewsj
HSL1734
O'Connell V.
Drug Marketers' Ads Penetrate Text of Online Medical Studies
Wall Street Journal 2002 Mar 28
http://online.wsj.com/article/SB1017264444467884800.html?mod=googlewsj
HSL1733
Arno P.
Paying Twice for the Same Drugs
Washington Post 2002 Mar 27
http://www.washingtonpost.com/ac2/wp-dyn/A22829-2002Mar26?language=printer
HSL1732
Walsh M.
When a Buyer for Hospitals Has a Stake in Drugs It Buys
New York Times 2002 Mar 26
http://www.nytimes.com/2002/03/26/business/when-a-buyer-for-hospitals-has-a-stake-in-drugs-it-buys.html?pagewanted=1
HSL1731
Zuckerman D.
Is Drug Safety Being Enron'd?
redflagsweekly 2002 Mar 25
HSL28
Lenzer J.
Alteplase for stroke: money and optimistic claims buttress the “brain attack“ campaign.
BMJ 2002 Mar 23;324:723-726
http://bmj.bmjjournals.com/cgi/content/full/324/7339/723
HSL1730
McGregor .
Ban on drug ads to stay: McLellan
The Ottawa Citizen 2002 Mar 23
HSL1974
Orellana C.
German doctors' links with drug firm investigated.
Lancet 2002 Mar 23;359:(9311):1039
http://linkinghub.elsevier.com/retrieve/pii/S0140673602081126
HSL1729
The menace of fake drugs in Nigeria
2002 Mar 22
HSL1728
McNeil D.
New List of Safe AIDS Drugs, Despite Industry Lobby
New York Times 2002 Mar 21
http://www.nytimes.com/2002/03/21/world/new-list-of-safe-aids-drugs-despite-industry-lobby.html?pagewanted=1
HSL20239
Winkens R, Dinant G-J
Rational, cost effective use of investigations in clinical practice
BMJ 2002 Mar 20;324:
HSL1727
Health-literate patients-an asset to society
European Federation of Pharmaceutical Industries and Associations 2002 Mar 19
HSL1725
Pallarito K.
Lawmakers pass resolution to press US Congress on lower drug prices
Reuters Health 2002 Mar 15
HSL1726
Fuhrmans V.
European Drug Makers May Utilize More Aggressive Marketing Tactics
The Wall Street Journal 2002 Mar 15
http://online.wsj.com/article/SB1016129314345304480.html?mod=googlewsj
HSL7764
Young D.
FTC-Lilly settlement sheds light on e-mail privacy with patients.
Am J Health Syst Pharm 2002 Mar 15;59:(6):509
http://www.ajhp.org/
HSL7983
Williams C.
Aspirin Can't Cure Bayer's Aches
Los Angeles Times 2002 Mar 15C4
http://pqasb.pqarchiver.com/latimes/access/110557388.html?dids=110557388:110557388&FMT=ABS&FMTS=ABS:FT&type=current&date=Mar+15%2C+2002&author=CAROL+J.+WILLIAMS&pub=Los+Angeles+Times&edition=&startpage=C.4&desc=Aspirin+Can%27t+Cure+Bayer%27s+Aches
HSL1722
Adams C.
FDA Is Inundated Trying To Assess Drug Ad Pitches
The Wall Street Journal 2002 Mar 14
http://online.wsj.com/article/SB1016053991820089240.html?mod=googlewsj
HSL1723
Hensley S.
More Than Ads, Drug Makers Rely on Sales Representatives
The Wall Street Journal 2002 Mar 14
HSL1724
Petersen M.
Whistle-Blower Says Marketers Broke the Rules to Push a Drug
New York Times 2002 Mar 14
http://www.nytimes.com/2002/03/14/business/whistle-blower-says-marketers-broke-the-rules-to-push-a-drug.html?pagewanted=all
HSL1717
Gardiner H.
Drug Makers Offer Consumers Coupons for Free Prescriptions
The Wall Street Journal 2002 Mar 13
http://online.wsj.com/article/0,,SB1015968588107926720.djm,00.html
HSL1718
Burton T.
Backlash Rises Against Flashy Ads For Prescription Pharmaceuticals
The Wall Street Journal 2002 Mar 13
http://online.wsj.com/article/SB1015968026351450840.html?mod=googlewsj
HSL1719
O'Connell V.
Ad Agencies Begin to Participate In Development of New Drugs
The Wall Street Journal 2002 Mar 13
HSL1721
German Public Prosecutor investigates doctors who have received gifts from GSK
Trouw newspaper 2002 Mar 13
HSL1715
Cleaver H.
Bribery of German Docs by Drug Companies
2002 Mar 11
http://story.news.yahoo.com/news?tmpl=story&cid=594&u=/nm/20020311/hl_nm/germany_docs_1
HSL1712
Metherell M.
Patients face drug rations
Sydney Morning Herald 2002 Mar 9
HSL1714
Craig T
Community Leaders Decry Lobby Firm's Fax
Baltimore Sun 2002 Mar 9
http://www.commondreams.org/headlines02/0309-04.htm
HSL16131
Eysenbach G, Köhler C.
How do consumers search for and appraise health information on the world wide web? Qualitative study using focus groups, usability tests, and in-depth interviews.
BMJ. 2002 Mar 9;324:(7337):573-7
http://www.bmj.com/cgi/content/full/324/7337/573?view=long&pmid=11884321
HSL1710
Moynihan R.
ACA urges cut to $4bn drug bill
Australian Financial Review 2002 Mar 8
HSL1711
Petersen M
TV Ads Spur a Rise in Prescription Drug Sales
New York Times 2002 Mar 8
http://www.nytimes.com/2002/03/08/business/08PRES.html
HSL1709
Italy suspends sales of sibutramine over adverse events
Reuters Health 2002 Mar 7
HSL1708
Avantago introduces mobile application built specifically for pharmaceutical sales
HAYWARD 2002 Mar 4
HSL17915
Avantgo Introduces Mobile Application Built Specifically For Pharmaceutical Sales
AvantGo, Inc 2002 Mar 4
HSL1713
Ottawa must protect public from drug ads
The Toronto Star 2002 Mar 3
HSL1707
Treating depression
2002 Mar 1
HSL2485
Castaigne A.
[Role of drugs in therapeutic strategies].
Rev Prat. 2002 March 1;52:(5):491-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11949500
HSL7808
Young D.
Drug industry sues states over prescription programs for low-income residents.
Am J Health Syst Pharm 2002 Mar 1;59:(5):408
http://www.ajhp.org/cgi/pmidlookup?view=reprint&pmid=11887405
HSL1716
How does pharmaceutical marketing influence doctors' prescribing behaviour?
2002 Mar
HSL1720
Jung P.
No Free Lunch
Health Affairs 2002 Mar
http://content.healthaffairs.org/cgi/content/full/21/2/226
HSL1741
McKinnell H.
Towards a sustainable solution - funding innovative medicines
Pharmapolicy News 2002 Mar
HSL1933
Spilker B.
The benefits and risks of a pack of M&Ms: A pharmaceutical spokesman answers his industry's critics
Health Affairs 2002 3-4;21:(2):243-244
http://content.healthaffairs.org/cgi/reprint/21/2/243?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Spilker+B&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
HSL1965
Rao SK.
Pharmaceutical marketing in a new age, Effective campaigns still need to focus on what customers want.
Mark Health Serv 2002 Spring;22:(1):6-12
Page 156 of 206 pages ‹ First < 154 155 156 157 158 > Last ›
